Yasmeen Rahimi

Yasmeen Rahimi

Analyst-Equity at Piper Sandler & Co. (Broker)

Finance
Consumer Services
Health Technology

Profile

Dr. Yasmeen Rahimi is a Senior Research Analyst at Piper Sandler & Co. She is also a director covering biotechnology.
Prior to joining Piper Sandler in July 2020, Dr. Rahimi was a senior research analyst and co-head of biotechnology equity research team at ROTH Capital Partners.
Before that, she worked as an equity research associate at H.C.
Wainwright & Co. and Guggenheim Securities.
Prior to making the transition to Wall Street, Rahimi was a research scientist at Shire Pharmaceuticals where she developed biomarker strategies for a number of rare disease programs; she has an extensive expertise in liver metabolism.
She received her Ph.D.
from Indiana University School of Medicine.
In addition, she has a M.S.
in Bioanalytical Chemistry from Purdue University and a joint B.A.
in German and Chemistry from Butler University.

Yasmeen Rahimi active positions

CompaniesPositionStart
Analyst-Equity 01/07/2020
All active positions of Yasmeen Rahimi

Former positions of Yasmeen Rahimi

CompaniesPositionEnd
Director of Research - Equity 01/07/2020
Analyst-Equity 01/09/2017
Corporate Officer/Principal 01/06/2016
Corporate Officer/Principal 01/07/2015
Yale University Corporate Officer/Principal 01/11/2014
See the detail of Yasmeen Rahimi's experience

Training of Yasmeen Rahimi

The Indiana University School of Medicine Doctorate Degree
Purdue University Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yasmeen Rahimi's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies5

Finance

Finance

Health Technology

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Yasmeen Rahimi